Scleroderma Renal Crisis (SRC) is a life-threatening complication of systemic sclerosis (SSc), traditionally associated with anti-RNA polymerase III antibodies, corticosteroid use, and diffuse skin involvement. However, the role of COVID-19 as a potential trigger for SRC remains poorly understood. This study explores the occurrence of COVID-19-associated SRC, focusing on its clinical presentation, underlying risk factors, and outcomes
This study evaluates the impact of ozone therapy on inflammation and respiratory parameters in COVID-19 patients. These factors are critical for clinical outcomes and survival rates, offering potential ways to improve patient recovery.